Hot Topics in Nephrology: Impact of Hurricanes Helene & Milton on Dialysis Care
Hurricane Helene impacted a North Carolina facility that produces peritoneal dialysis fluid used by about 80,000 people nationally. Read More
- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
All Resources
Breakdown of the MEST-C Score in IgA Nephropathy
This podcast provides an in-depth review of the Oxford MEST-C score, focusing on its practical application in diagnosing and prognosticating IgA Nephropathy. Read MoreRole of the Renal Pathologist in IgA Nephropathy
Through the lens of renal pathology, this webinar will provide insights into the histopathological features that are crucial for accurate diagnosis and risk stratification in IgA Nephropathy, highlighting the significance… Read MoreIgA Nephropathy in Kidney Transplantation
Join us to hear from Dr. Fahad Aziz, Associate Profession of Nephrology, and Transplant Nephrologist at the University of Wisconsin, Madison, to learn more about IgAN in kidney transplantation. Read MoreKidney Transplant In Patients With IgA Nephropathy (IgAN)
Learn about issues relating to kidney transplantation and IgAN. Read MoreHot Topics in Nephrology: The Increasing Organ Transplant Access (IOTA) Model
Learn about the proposed Increasing Organ Transplant Access Model, which aims to increase access to kidney transplants for patients living with kidney disease and reduce Medicare expenditures. Read MoreUtilization of the International IgA Nephropathy Prediction Tool
Learn about the clinical, laboratory and histological risk predictors that make up the International IgAN Prediction Tool and gain an understanding of its clinical utility and future potential. Read MoreRisk of Progression to ESKD in IgA Nephropathy
This infographic highlights the risk of progression to ESKD, including in patients traditionally considered low risk. Read MoreOverview of IgAN
This infographic focuses on IgAN diagnosis, prognosis, and disease management strategies. Read MoreAPRIL & the 4-Hit Pathogenic Cascade of IgAN
This infographic highlights the role of APRIL in a pre-hit 1 step that drives the 4-hit cascade.1 References 1. Mathur M, et al. J Clin Med. 2023;12(21):6927. Read MoreNephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
